Large and small artery endothelial function in patients with essential hypertension - Effect of ACE inhibition and beta-blockade

Blood Pressure

Volumn 16, Issue 2, 2007, Pages 106-113

  Buus, Niels H ^a   Jørgensen, Claus G ^b   Mulvany, Michael J ^a   Sørensen, Keld E ^c  

^a AARHUS UNIVERSITY   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acetylcholine; Antihypertensive treatment; Flow mediated dilatation; Hypertension; Resistance artery

Indexed keywords

ACETYLCHOLINE; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; PERINDOPRIL;

ADULT; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY RESISTANCE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; FOREARM; HUMAN; IN VIVO STUDY; ISCHEMIA; MALE; MYOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

ACETYLCHOLINE; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASODILATION;

EID: 34447336651     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050701343688     Document Type: Article

References (40)

1. Lewington, S., Clarke, R., Qizilbash, N., Peto, R. and Collins, R. (2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 360, pp. 1903-1913.
2. Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I. and Sullivan, I. D. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, pp. 1111-1115.
3. Halcox, J. P., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A. and Waclawiw, M. A. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation, 106, pp. 653-658.
4. Laurent, S., Lacolley, P., Brunel, P., Laloux, B., Pannier, B. and Safar, M. (1990) Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol, 258, pp. H1004-H1011.
5. Mitchell, G. F., Parise, H., Vita, J. A., Larson, M. G., Warner, E. and Keaney, Jr. (2004) Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension, 44, pp. 134-139.
6. Levenson, J., Pessana, F., Gariepy, J., Armentano, R. and Simon, A. (2001) Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol, 38, pp. 1668-1674.
7. Betik, A. C., Luckham, V. B. and Hughson, R. L. (2004) Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. Am J Physiol, 286, pp. H442-H448.
8. Celermajer, D. S., Sorensen, K. E., Bull, C., Robinson, J. and Deanfield, J. E. (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol, 24, pp. 1468-1474.
9. Gnasso, A., Carallo, C., Irace, C., De Franceschi, M. S., Mattioli, P. L. and Motti, C. (2001) Association between wall shear stress and flow-mediated vasodilation in healthy men. Atherosclerosis, 156, pp. 171-176.
10. Pyke, K. E., Dwyer, E. M. and Tschakovsky, M. E. (2004) Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans. J Appl Physiol, 97, pp. 499-508.
11. Buus, N. H., Bottcher, M., Jorgensen, C. G., Christensen, K. L., Thygesen, K. and Nielsen, T. T. (2004) Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension, 44, pp. 465-470.
12. Sorensen, K. E., Celermajer, D. S., Spiegelhalter, D. J., Georgakopoulos, D., Robinson, J. and Thomas, O. (1995) Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J, 74, pp. 247-253.
13. Buus, N. H., Bottcher, M., Bottker, H. E., Sorensen, K. E., Nielsen, T. T. and Mulvany, M. J. (1999) Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. Am J Cardiol, 83, pp. 149-154.
14. Sorensen, K. E., Dorup, I., Hermann, A. P. and Mosekilde, L. (1998) Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation, 97, pp. 1234-1238.
15. Thybo, N. K., Stephens, N., Cooper, A., Aalkjaer, C., Heagerty, A. M. and Mulvany, M. J. (1995) Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension, 25, pp. 474-481.
16. Joannides, R., Haefeli, W. E., Linder, L., Richard, V., Bakkali, E. H. and Thuillez, C. (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation, 91, pp. 1314-1319.
17. Doshi, S. N., Naka, K. K., Payne, N., Jones, C. J., Ashton, M. and Lewis, M. J. (2001) Flow-mediated dilatation following wrist and upper arm occlusion in humans: The contribution of nitric oxide. Clin Sci (Lond), 101, pp. 629-635.
18. Thorsgaard, M., Lopez, V., Buus, N. H. and Simonsen, U. (2003) Different modulation by Ca2+-activated K+ channel blockers and herbimycin of acetylcholine- and flow-evoked vasodilatation in rat mesenteric small arteries. Br J Pharmacol, 138, pp. 1562-1570.
19. Paniagua, O. A., Bryant, M. B. and Panza, J. A. (2001) Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: Diminished activity in hypertensive and hypercholesterolemic patients. Circulation, 103, pp. 1752-1758.
20. Muiesan, M. L., Salvetti, M., Monteduro, C., Corbellini, C., Guelfi, D. and Rizzoni, D. (2001) Flow-mediated dilatation of the brachial artery and left ventricular geometry in hypertensive patients. J Hypertens, 19, pp. 641-647.
21. Olsen, M. H., Wachtell, K., Hermann, K. L., Bella, J. N., Dige-Petersen, H. and Rokkedal, J. (2002) Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudy. Blood Press, 11, pp. 285-292.
22. Ghiadoni, L., Magagna, A., Versari, D., Kardasz, I., Huang, Y. and Taddei, S. (2003) Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension, 41, pp. 1281-1286.
23. Lauer, T., Hei, C., Preik, M., Balzer, J., Hafner, D. and Strauer, B. E. (2005) Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension. J Hypertens, 23, pp. 563-569.
24. Muiesan, M. L., Salvetti, M., Monteduro, C., Rizzoni, D., Zulli, R. and Corbellini, C. (1999) Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension, 33, pp. 575-580.
25. Komai, N., Ohishi, M., Morishita, R., Moriguchi, A., Kaibe, M. and Matsumoto, K. (2002) Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients. Am J Hypertens, 15, pp. 499-506.
26. Munakata, M., Aihara, A., Nunokawa, T., Ito, N., Imai, Y. and Ito, S. (2003) The influence of one-year treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow-mediated vasodilation of the brachial artery in essential hypertension-Comparison with calcium channel blockers. Clin Exp Hypertens, 25, pp. 169-181.
27. Chung, N. A., Beevers, D. G. and Lip, G. (2004) Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension. Blood Press, 13, pp. 183-189.
28. Hornig, B., Landmesser, U., Kohler, C., Ahlersmann, D., Spiekermann, S. and Christoph, A. (2001) Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: Role of superoxide dismutase. Circulation, 103, pp. 799-805.
29. Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., Pasini, A. F. and Garbin, U. (2001) Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. J Hypertens, 19, pp. 1379-1386.
30. Baykal, Y., Yilmaz, M. I., Celik, T., Gok, F., Rehber, H. and Akay, C. (2003) Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens, 21, pp. 1207-1211.
31. Buus, N. H., Simonsen, U., Pilegaard, H. K. and Mulvany, M. J. (2000) Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol, 129, pp. 184-192.
32. Panza, J. A., Quyyumi, A. A., Brush, Jr. and Epstein, S. E. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med, 323, pp. 22-27.
33. Rossi, M., Taddei, S., Fabbri, A., Tintori, G., Credidio, L. and Virdis, A. (1997) Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol, 29, pp. 406-411.
34. Cockcroft, J. R., Chowienczyk, P. J., Benjamin, N. and Ritter, J. M. (1994) Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med, 330, pp. 1036-1040.
35. Schiffrin, E. L. and Deng, L. Y. (1996) Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens, 14, pp. 1247-1255.
36. Rizzoni, D., Muiesan, M. L., Porteri, E., Castellano, M., Zulli, R. and Bettoni, G. (1997) Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens, 15, pp. 197-204.
37. Christensen, F. H., Hansen, T., Stankevicius, E., Buus, N. H. and Simonsen, U. (2007) Elevated pressure selectively blunts flow-evoked vasodilatation in rat mesenteric small arteries. Br J Pharmacol, 150, pp. 80-87.
38. Schiffrin, E. L., Deng, L. Y. and Larochelle, P. (1994) Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension, 23, pp. 83-91.
39. Thybo, N. K., Mulvany, M. J., Jastrup, B., Nielsen, H. and Aalkjaer, C. (1996) Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens, 14, pp. 993-998.
40. Schiffrin, E. L., Park, J. B. and Pu, Q. (2002) Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens, 20, pp. 71-78.